Structured JSON API for this factor page: https://sharemaestro.com/factors/api/tickers/6d6ab096-54d8-4231-992f-9fd6992f77e6/

VMD

Viemed Healthcare Inc
Chart
$9.97
Latest Week 2026-06-05
Snapshot 2026-06-07 · 0.0w · Fresh
0.9
OS Score
69.0%
Value
83.0%
Quality
81.0%
Momentum
4/9
F-Score
0.757
QV
Strategy Eligibility
4 of 23 passing
OS Composite
OS 0.900
Trending Value
Quality × Value
QV 0.757
🏛
Cornerstone Value
🌿
Cornerstone Growth
💎
Deep Value
VC2 Cheapest
📐
EBITDA/EV
13.2%
Veiled Value
Piotroski Bargains
🔬
Quality Compounders
📈
Consistent Earners
🌱
GARP
🔄
Shareholder Yield
💰
High Yield
🚀
Momentum Leaders
12-1 33%
Market Leaders
Tiny Titans
🔍
Small Cap Value
🛡
Low Volatility
🏷
Sector Cheapest
🧠
Capital Allocators
Risk-Adj Momentum
V
Value Analysis
Cheapness relative to fundamentals
69.0%ile
P/E
27.1×
P/S
1.4×
P/B
2.8×
E/P
0.0369
FCF Yield
0.218
EBITDA/EV
0.132
SH Yield
0.000
Relative Strength Across Value Dimensions
Multiples & Yields — Decomposition
VC1 (5-Factor)
27.00000000
/100 — 1=cheapest
VC2 (Trending Value)
70.00000000
/100
VC3 (Buyback)
70.00000000
/100
FCF yield of 21.8% is strong — the business generates significant free cash relative to price.
Q
Quality Analysis
Profitability, efficiency, balance sheet & earnings quality
83.0%ile
ROE
0.104
ROA
0.075
Net Margin
0.052
Op Margin
0.083
GPA
0.832
D/E
0.36
Current
1.22
F-Score
4/9
Quality Radar — Relative Strength
Profitability & Leverage Breakdown
Rev Growth
0.231
Earn Growth
0.212
Stability
0.372
lower=better
Accruals
-0.214
lower=better
5yr Consist
No
Conservative balance sheet with D/E of 0.36.
M
Momentum & Risk
Price trend, volatility regime, risk-adjusted returns
81.0%ile
6M Return
47.3%
12M Return
48.4%
12-1 Mom
33.0%
Risk-Adj
0.92
Vol 252d
35.8%
Vol 60d
65.5%
↑ Expanding
Max DD 12M
-17.1%
Return Comparison — 6M / 12M / 12-1
Volatility Regime — 60d vs 252d
12-1 momentum of 33% is very strong — a clear uptrend. Near-term vol (65%) is expanding vs long-term (36%) — risk is increasing.
OS
Composite & Factor Heatmap
All factors at a glance
0.9
Pillar Balance — Value / Quality / Momentum
Factor Heatmap — green=strong, red=weak
Sector Context
Healthcare · 500 peers
Sector Value %ile
81.4%
Sector Quality %ile
87.0%
P/E z-score
0.03
P/B z-score
-0.18
Sector Avg OS
63.2%
Ticker vs Sector Averages
Relative Valuation Z-Score
Top Sector Peers (By OS)
SymbolNameOSValueQualityMomentum
IRWD Ironwood Pharmaceuticals Inc 99.0% 93.0% 86.0% 98.0%
RIGL Rigel Pharmaceuticals Inc 98.0% 94.0% 92.0% 76.0%
FBIO Fortress Biotech Inc 98.0% 97.0% 93.0% 74.0%
CGEN Compugen 97.0% 90.0% 95.0% 76.0%
PBYI Puma Biotechnology Inc 97.0% 80.0% 97.0% 92.0%
WW WW International, Inc. Common Stock 97.0% 88.0% 80.0% 99.0%
FBIOP Fortress Biotech Inc Pref Series A 97.0% 81.0% 95.0% 90.0%
MD Mednax Inc 96.0% 87.0% 80.0% 87.0%
Factor Interactions
Volatility Expanding
60-day vol (65%) significantly exceeds 252-day (36%). Near-term risk is elevated.
Factor Analysis
Comprehensive factor intelligence — strengths, weaknesses & cross-factor profile
Value
C
59.2% avg (7 factors)
Quality
C
57.4% avg (8 factors)
Momentum
A
77.3% avg (4 factors)
Risk
C
56.9% avg (1 factors)
▲ Top Strengths — highest scoring factors
▼ Key Weaknesses — lowest scoring factors
Factor Persistence1 snapshots
FactorCurrentStreakTrendSpark
OS Composite0.900—1
Value %ile0.690—0
Quality %ile0.830—1
Momentum %ile0.810—1
F-Score4.000—1
Confidence1.000—1
Volatility0.358—0
Value FactorsCheapness relative to fundamentals — lower multiples = cheaper
P/E Ratio
27.11
Earnings Yield (E/P)
0.0369
Price / Sales
1.41
Price / Book
2.81
Price / Cash Flow
7.07
FCF Yield
21.8%
EBITDA / EV
13.2%
Sales Yield (1/P·S)
0.7087
Shareholder Yield
Div + net buyback / mktcap
0.0%
Quality FactorsProfitability, efficiency, and balance sheet strength
Return on Equity
10.4%
Return on Assets
7.5%
Net Margin
5.2%
Operating Margin
8.3%
Gross Profit / Assets
Novy-Marx GPA
83.2%
Debt / Equity
0.36
Current Ratio
1.22
Accruals Ratio
(NI-OCF)/Assets — lower=better
-0.214
MomentumPrice trend strength over different horizons
6M Return
47.3%
12M Return
48.4%
12-1 Momentum
Jegadeesh-Titman (skip recent month)
33.0%
Risk-Adjusted Momentum
Mom 12-1 ÷ Vol
0.92
Growth & StabilityEarnings trajectory, consistency, and capital allocation
Revenue Growth (YoY)
23.1%
Earnings Growth (YoY)
21.2%
Earnings Stability (CV)
Lower = more stable
0.372
5yr Consistent
EPS up every year for 5 years
No
Piotroski F-Score
4
Dividend Yield
0.0%
Buyback Yield
0.0%
O'Shaughnessy CompositesValue Composites (WWOWS 4th Ed) — 1=cheapest, 100=most expensive
VC1 (5-factor)
P/E+P/S+P/B+P/CF+EBITDA/EV
27
VC2 (6-factor)
VC1 + Shareholder Yield — used for Trending Value
70
VC3 (6-factor)
VC1 + Buyback Yield — no dividend preference
70
Capital Allocation & AlphaAlpha within factors — quality of management decisions
Veiled Value
Expensive by P/B, cheap by everything else
No
Market Leader
Above-avg mcap+revenue, non-utility
No
All Stocks Universe
Market cap > $200M
Yes
Tiny Titan
Micro-cap, low P/S, positive momentum
No
Quarterly Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity
Annual Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity